{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-032162","form_type":"8-K","ticker":"ASMB","cik":"0001426800","company_name":"ASSEMBLY BIOSCIENCES, INC.","filed_at":"2024-03-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.156489+00:00","generated_at":"2026-06-04T16:59:31.160906+00:00","sec_items":["5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Assembly Biosciences appoints Gilead designee to board, adopts 2024 bonus plan","bullets":["Robert D. Cook II, Gilead's VP of Risk Governance and Audit, appointed to Board as Gilead designee per Oct 15, 2023 Investor Rights Agreement; no compensation.","Compensation Committee approved 2024 Corporate Bonus Plan effective Jan 1 2024 with cash bonuses tied to corporate and individual objectives.","CEO bonus target up to 75% of base salary; other executive participants 30-55%; non-executive participants up to 28%.","Cash bonuses range from 0 to 1.5x target; paid by March 15 following performance year; employment through payment date required.","Weighting: CEO 100% corporate; C-Level/SVP 75/25; VP/Exec Dir/Sr Dir 50/50; below Sr Dir 25/75."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-032162","json":"https://secwatch.observer/filing/0000950170-24-032162.json","markdown":"https://secwatch.observer/filing/0000950170-24-032162.md","text":"https://secwatch.observer/filing/0000950170-24-032162.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1426800/000095017024032162/0000950170-24-032162-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1426800/000095017024032162/asmb-20240312.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T16:59:31.160906+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"710bacdb6a","claim":"Robert D. Cook II was appointed as Director at ASSEMBLY BIOSCIENCES, INC..","evidence_excerpt":"On March 13, 2024, the Board appointed Robert D. Cook II, a designee of Gilead Sciences, Inc. (\"Gilead\"), to serve on the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017024032162/0000950170-24-032162-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}